retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I assure you this type of injection is quite tolerable. I am a pharmacist and have attended seminars where I tried the needle on myself. You cannot feel it it is so tiny. As well, it is just once a week injection. I would much rather do that then take a pill or inject daily. Too bad there are all these adverse effects. GlP-1 has been quite a miracle drug up to this point.
Obviously GM had a hand in Milton's departure. GM basically said the deal would be annulled if Milton stayed on. That's enough for the bod to turf Milton.
I see a falling knife. Save an announcement of major contract, NKLA will continue downwards in the short term. Good support at 200 day MA of 20.50 but I think it will break that support. May mire around $10 until they announce Badger partner and stay in narrow trading range of $10 to $20 until trucks roll off assembly line in Germany in 2021.
Stock holding up pretty good under pressure of PIPE dumping. Think the dumping is done? Yesterday 30 some million shares -- quite above the norm.
Because its opex mms are trying to peg the price to $15 to wipe out both calls and puts at that strike price.
Is this the effect of PIPE offloading their shares?
This is a very insightful article which nails it on the head in explaining why NKLA, while having never made a sale, is valued at 25 billion.
https://cleantechnica.com/2020/06/25/what-nikola-corporations-nklas-stock-price-tells-us-and-what-it-doesnt/
Mr. Ytse, do you know the strike price of these warrants>
NKLA is going against the grain. Are we surprised? How many stocks go up 100% on next to no news? Would not surprise if it recovered 70 today.
Stalling here. A pullback is needed. Rest of market needs a rest too. So maybe good time to take profits on trading shares.
I just read the FAQ on the NKLA website. It said if you had 1000 shares of VTIQ and held it to conversion you would then own 1000 shares of NKLA and 1000 shares of NKLAW. Did you people know that?
I made the mistake of selling the stock at $35 but got back into the warrants today. NKLA appears to be spearheading a paradigm shift. It may very well be the Amazon of the green fuel czars. I dont think it CAN go down.
I think this IS the IPO taking place. However, VTIQ provides a backdoor to get in the IPO. Most times we pay thru the teeth for the IPO. Not so via a reverse merger!
I am a pharmacist in Canada. Shingrix has had great uptake. It is an inactivated vaccine so immunocompromised people may need not avoid it (more research needed before final conclusion). With the previous and only vaccine, Zostavax, a live vaccine, people afflicted with shingles would need to wait a year before being immunized. However, such a restriction may not need apply with Shingrix. Victims may be immunized as soon as condition crusts over. As well, Shingrix may be 97% effective vs 50% with former. And it may last 19 years vs 10.
What is the strike price for SRPTW? Cant seem to find this info.
Kirk basically sold the investor down the river. I am sure Viibryd will exceed the milestones in the CVR. Look at Pristiq,desvenlafaxine, which is an active metabolite of venlafaxine. According the the pharmacist letter ..., European regulators say that Pristiq seems less effective than venlafaxine for depression...and isn't better tolerated.
Docs are prescribing Pristiq even though generic and Effexor XR are cheaper. I think Pristiq brings in 800 million per year.
I wonder if Mr. Dew thinks this is now the "right" time to short CLDA....
They didnt get the name "fools" for no reason :p
I read the transcript of Kirk's interview. Knowing Kirk's past business dealings, what he uttered came as no surprise. He never ever partnered or licenced out. He only wants to sell the entire company. Thats how he operates. Todays sell off was a profit taking event and a huge buying opportunity!
Mr. Dew, that is a cop out. Most stocks eventually become shortable, even AAPL CLF GOOG at least for a short duration if you wait long enough. Put your money where your mouth is and short CLDA NOW! I dare you!
I have access to the McKesson catalogue. 100 Trazodone 50mg costs $22.14. I happen to be a pharmacist and we still sell a lot of Trazodone for both depression and insomnia. I would have to do some figuring to what we sold in the way of all the various strengths in 2010. It would not surprise me that it would number $5000 or so. And thats just one pharmacy, a not all that busy one at that. So find out how many pharmacies there are in the US and multiply by that amount.
The point is Vilazodone has fewer side effects. Doctors like that so they will use it until clinically proven otherwise.
Serzone was eventually pulled from the market because of liver toxicity. Prior to getting yanked Serzone was bringing in good loot. Trazodone, tho genericized, is a mainstay of many therapies, whether for traditional anti depressing or for insomnia. For sure, Trazodone pulls in over a billion bucks in total for the various generic houses. If Viladazone is anything like Trazodone then it will be very successful. Dew, short all you want -- you gonna be a poor man.
MON, Mr. Dew, I notice MON had been on a steady decline from January 2010 ($86) to early July ($45) where it turned around and has been on a tear lately, the general market notwithstanding. Was there a reason for it to perform so poorly during those 7 months? And why the sudden turn around. I also read that insiders have made big purchases just recently.
OT: killing of officers in Florida. I dont know why police havent adopted a new policy of requiring occupants of a vehicle to exit the vehicle and place their hands on the car roof until the officers approach. This may seem a little severe but I am sure this would save many officers lives. I for one would not be offended if required to follow this procedure during a routine traffic stop. These deaths seem so unnecessary.
DNDN: Does anyone know the current cost for chemotherapy in the treatment of prostate cancer? I just wonder how that compares to 93k for Provenge. Of course there are follow up costs just like there would be for normal chemo.
Gulf catastrophe: I am not an engineer but I just wonder why there arent more stringent safeguards wrt offshore oil rigs. Surely, govts have time and again seen accidents that result in blow outs. Why dont they require oil companies to have redundant backup mechanisms to prevent a disaster as we are seeing? For instance why isnt this underwater pipeline segmented with shutoff valves for each segment so that any rupture could be isolated, as submarines and ships are also similarly safeguarded. Any oil industry person could answer these questions?
CLDX - an DNDN kin also threatens to blow the roof off
KERX -- smoking and nobody knows why???
KERX running crazily. Does anyone know why?
Nice move BBull. You must use voodoo or something!
POZN will likely be the next big mover. PDAUF on April 30th!
ACUR -- a typical short squeeze before April 22nd FDA panel?
gapper BZH on apparently no news
DNDN Is there any doubt now that the partner/acquirer of DNDN after approval will be Roche? lst they put the Roche CEO on the DNDN board and now they have transferred over the Roche global operations chief.
ACUR ramping. FDA panel on April 22nd!
POZN ripping along. FDA approval date April 30th
EXEL ramping...whats the story?
SQNM maybe a bargain in a few days. Why would they tank it on earnings? Its a biotech, still developing new products. People actually expect them to make money at this point?
ONCY -- oh, this is old news? Sorry, I thought Reovirus was a recent find. I just heard about this treatment on Canadian National news last night. Oh good...my DNDN investment is safe for now :P
Reovirus--a recent finding that this virus can kill prostate cancer cells. These are Canadian researchers and they are only entering phase I trial. This could have major implications for not only companies like DNDN but other oncology companies as well.
http://www.nhs.uk/news/2010/03March/Pages/Virus-kills-prostate-cancer.aspx